Dordaviprone

69 interactions 4 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ketoconazole Topical Dexamethasone Ophthalmic Gatifloxacin Ophthalmic Relugolix Octreotide Injection Ofloxacin Otic

1 Contraindicated 68 Major

All (69) Contraindicated (1) Major (68)

Contraindicated

Dordaviprone Ketoconazole Topical Extina® Foam An increased risk of QT interval prolongation, increased dordaviprone exposure and an increased risk of dordaviprone-related adver... Details

Major

Dordaviprone Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Dordaviprone Sertraline Explained An increased risk of QT interval prolongation Details Dordaviprone Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Dordaviprone Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Dordaviprone Amisulpride Injection Barhemsys An increased risk of QT interval prolongation Details Dordaviprone Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Dordaviprone Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Dordaviprone Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Dordaviprone Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Dordaviprone Azithromycin AzaSite An increased risk of QT interval prolongation Details Dordaviprone Alfuzosin UroXatral An increased risk of QT interval prolongation Details Dordaviprone Anagrelide Agrylin An increased risk of QT interval prolongation Details Dordaviprone Bedaquiline Sirturo An increased risk of QT interval prolongation Details Dordaviprone Chloroquine Aralen® An increased risk of QT interval prolongation Details Dordaviprone Dasatinib Phyrago An increased risk of QT interval prolongation Details Dordaviprone Degarelix Injection Firmagon An increased risk of QT interval prolongation Details Dordaviprone Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Dordaviprone Dexamethasone Injection Decadron Reduced dordaviprone exposure and reduced efficacy of dordaviprone Details Dordaviprone Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Reduced dordaviprone exposure and reduced efficacy of dordaviprone Details Dordaviprone Disopyramide Norpace An increased risk of QT interval prolongation Details Dordaviprone Dofetilide Tikosyn An increased risk of QT interval prolongation Details Dordaviprone Dolasetron Anzemet An increased risk of QT interval prolongation Details Dordaviprone Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Dordaviprone Encorafenib Braftovi An increased risk of QT interval prolongation, reduced dordaviprone exposure and reduced efficacy of dordaviprone Details Dordaviprone Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Dordaviprone Eribulin Injection Halaven An increased risk of QT interval prolongation Details Dordaviprone Famotidine Calmicid An increased risk of QT interval prolongation Details Dordaviprone Famotidine Injection Calmicid An increased risk of QT interval prolongation Details Dordaviprone Felbamate Felbatol An increased risk of QT interval prolongation Details Dordaviprone Flecainide Tambocor® An increased risk of QT interval prolongation Details Dordaviprone Foscarnet Injection Foscavir An increased risk of QT interval prolongation Details Dordaviprone Galantamine Razadyne An increased risk of QT interval prolongation Details Dordaviprone Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Dordaviprone Gemifloxacin Factive An increased risk of QT interval prolongation Details Dordaviprone Glasdegib Daurismo An increased risk of QT interval prolongation Details Dordaviprone Goserelin Implant Zoladex An increased risk of QT interval prolongation Details Dordaviprone Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Dordaviprone Granisetron Injection Granisol An increased risk of QT interval prolongation Details Dordaviprone Histrelin Implant Supprelin An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.